|
|||||
|
|
| 厄贝沙坦／氢氯噻嗪复方片剂治疗原发性高血压 | |
| 引用本文： | 王晓琴. 厄贝沙坦／氢氯噻嗪复方片剂治疗原发性高血压[J]. 临床医学, 2009, 29(1): 19-20 |
| 作者姓名： | 王晓琴 |
| 作者单位： | 安徽省淮北市第一人民医院心血管内科,淮北,235000 |
| 摘 要： | 目的评价厄贝沙坦／氢氯噻嗪复方片剂治疗原发性高血压的有效性和安全性。方法80例原发性高血压患者服用厄贝沙坦／氢氯噻嗪复方片剂，疗程4周。结果80例中显效47例（58．75％），有效26例（32．5％），无效7例（8．75％），总有效率91．25％，治疗4周后与治疗前比较，坐位血压明显下降，治疗前为（170±15）／（98±8）mmHg，治疗后为（137±10）／（76±7）mmHg，但心率无明显变化（P〉0．05）。检测24h动态血压，计算降压谷峰比值率〉65％。结论厄贝沙坦／氢氯噻嗪复方片剂治疗原发性高血压安全有效。 |
| 关 键 词： | 厄贝沙坦/氢氯噻嗪 高血压 临床分析 治疗方法 |
The therapeutic effect of irbesartan/hydrochlorothiazide tablets compound in the treatment of patients with essential hypertension |
|
| WANG Xiaoqin. The therapeutic effect of irbesartan/hydrochlorothiazide tablets compound in the treatment of patients with essential hypertension[J]. Clinical Medicine, 2009, 29(1): 19-20 | |
| Authors: | WANG Xiaoqin |
| Affiliation: | WANG Xiaoqin.Department of Cardiovascular Disease,the First People's Hospital of Huaibei,Huaibei 235000,China |
| Abstract: | Objective To evaluate of the effectiveness and safety of irbesartan/hydrochlorothiazide compound in the treatment of effential hypertension.Methods Eighty cases of essential hypertension taking irbesartan/hydrochlorothiazide tablets compound,course of four weeks.Results Markedly effective in 47 cases(58.75%),effctive in 26 cases(32.5%,invalid in 7 cases(8.75%),and the total effective power was 91.25%.Sitting blood pressure decreased significantly four weeks after treatment compared with before treatment[bef... |
| Keywords: | Irbesartan/hydrochlorothiazide Hypertension |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |